Strategy shift bearing fruit for PharmX

Healthcare technology provider focused on profitability following lengthy court case  PharmX is reporting continued revenue growth as it focuses on technology enhancement and market expansion.   Addressing the company’s annual general meeting on Tuesday (26 November 2024) chair Nick English said PharmX aimed to grow its supplier base in the 2025 financial year, with the